
A study evaluated the safety and efficacy of a new micro-controlled radiofrequency device for treating conjunctivochalasis (Cch) in 127 patients (230 eyes). Cch coagulation was performed using the OcuRF® electrode tip and Acutron™ high-frequency radio-wave electric unit. Postoperative assessments included Cch grading, slit-lamp photography, tear film break-up time (TBUT), and bulbar conjunctival hyperemia. Success was defined as achieving a Cch grade of 0 or 1 post-surgery. Results showed 224 eyes (97.4%) achieved grade 0 or 1 at two months, with TBUT improving from 3.17 ± 0.82s to 5.28 ± 1.10s (P < 0.001). Bulbar conjunctival hyperemia improved from 1.7 ± 0.6 to 1.4 ± 0.6 (P < 0.05). No serious complications were reported, indicating the device is a safe and effective treatment for Cch.
Like
Save
Share